Publicacións nas que colabora con Sonia Eiras Penas (8)

2022

  1. The Effect of Mineralocorticoid Receptor 3 Antagonists on Anti-Inflammatory and Anti-Fatty Acid Transport Profile in Patients with Heart Failure

    Cells, Vol. 11, Núm. 8

2021

  1. A New Biomarker Tool for Risk Stratification in “de novo” Acute Heart Failure (OROME)

    Frontiers in Physiology, Vol. 12

2020

  1. CD5L, Macrophage Apoptosis Inhibitor, Was Identified in Epicardial Fat-Secretome and Regulated by Isoproterenol From Patients With Heart Failure

    Frontiers in Physiology, Vol. 11

  2. High released lactate by epicardial fat from coronary artery disease patients is reduced by dapagliflozin treatment

    Atherosclerosis, Vol. 292, pp. 60-69

  3. Inflammatory and lipid regulation by cholinergic activity in epicardial stromal cells from patients who underwent open-heart surgery

    Journal of Cellular and Molecular Medicine, Vol. 24, Núm. 18, pp. 10958-10969

2018

  1. Effects of dapagliflozin on human epicardial adipose tissue: Modulation of insulin resistance, inflammatory chemokine production, and differentiation ability

    Cardiovascular Research, Vol. 114, Núm. 2, pp. 336-346

2010

  1. Relationship between epicardial adipose tissue adipocyte size and MCP-1 expression

    Cytokine, Vol. 51, Núm. 2, pp. 207-212

2008

  1. Extension of coronary artery disease is associated with increased IL-6 and decreased adiponectin gene expression in epicardial adipose tissue

    Cytokine, Vol. 43, Núm. 2, pp. 174-180